Merck Expands Protein A Capabilities with JSR Chromatography Acquisition

1

Merck has acquired the chromatography business of JSR Life Sciences, enhancing its bioprocessing portfolio.
2

The acquisition includes Amsphere Protein A resins, crucial for monoclonal antibody manufacturing.
3

More than 50 employees and technical expertise in chromatography were integrated into Merck's operations.
4

This expansion aims to improve process consistency and support efficient biologics manufacturing.
5

Merck's acquisition is designed to accelerate access to critical therapies for customers.

1